Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 55.6% decrease from the number of companies cited in the previous quarter.
Of the 14 citations issued, the most common citations include:
- Procedures have not been adequately established to control product that does not conform to specified requirements.
- Procedures for corrective and preventive action have not been adequately established.
- Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been adequately established.
Most of the companies cited were involved in the Devices sector.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
3-D Matrix, Inc. | Devices | 10/18/2023 | Documented evaluation |
3-D Matrix, Inc. | Devices | 10/18/2023 | Calibration, Inspection, etc. Procedures Lack of or Inadequ |
3-D Matrix, Inc. | Devices | 10/18/2023 | Lack of or inadequate process validation |
3-D Matrix, Inc. | Devices | 10/18/2023 | Nonconforming product, Lack of or inadequate procedures |
3-D Matrix, Inc. | Devices | 10/18/2023 | Lack of or inadequate procedures |
3-D Matrix, Inc. | Devices | 10/18/2023 | Lack of or inadequate procedures for handling |
3-D Matrix, Inc. | Devices | 10/18/2023 | Lack of or inadequate complaint procedures |
Brammer Bio MA, LLC | Biologics | 12/19/2023 | SOPs not followed / documented |
Philips North America | Devices | 12/13/2023 | Nonconforming product, Lack of or inadequate procedures |
Philips North America | Devices | 12/13/2023 | Lack of or inadequate procedures |
Philips North America | Devices | 12/13/2023 | Lack of or inadequate complaint procedures |
The Dough Connection Corporation | Food and Cosmetics | 12/19/2023 | Qualifications of individuals |
The Dough Connection Corporation | Food and Cosmetics | 12/19/2023 | Pest control |
The Dough Connection Corporation | Food and Cosmetics | 12/19/2023 | Food safety plan |